Photodynamic Therapy with Pagetex Device for Vulvar EMPD
Fuente:
Zenodo
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Veröffentlicht: |
Zenodo
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866901175732797440 |
|---|---|
| author | MedicOath Autonomous Discovery Engine |
| author_facet | MedicOath Autonomous Discovery Engine |
| contents | Photodynamic therapy (PDT) uses photosensitizers activated by specific wavelengths to generate reactive oxygen species. Clinical trial NCT03713203 is testing the PAGETEX PDT device specifically for vulvar EMPD. OpenAlex cites multiple papers on PDT advances (cited:144, cited:87) showing efficacy in cutaneous malignancies through selective tumor destruction. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19833146 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Photodynamic Therapy with Pagetex Device for Vulvar EMPD MedicOath Autonomous Discovery Engine Extramammary Paget disease drug repurposing MedicOath mechanism_extension Photodynamic therapy (PDT) uses photosensitizers activated by specific wavelengths to generate reactive oxygen species. Clinical trial NCT03713203 is testing the PAGETEX PDT device specifically for vulvar EMPD. OpenAlex cites multiple papers on PDT advances (cited:144, cited:87) showing efficacy in cutaneous malignancies through selective tumor destruction. |
| title | Photodynamic Therapy with Pagetex Device for Vulvar EMPD |
| topic | Extramammary Paget disease drug repurposing MedicOath mechanism_extension |
| url | https://doi.org/10.5281/zenodo.19833146 |